Engineered human pluripotent stem cell-derived cardiac cells and tissues for electrophysiological studies

Drug Discovery Today: Disease Models

Volumn 9, Issue 4, 2012, Pages

  Lieu, Deborah K ^a,b   Turnbull, Irene C ^a   Costa, Kevin D ^a   Li, Ronald A ^a,c,d  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

^d UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

NEU DIFFERENTIATION FACTOR; NOGGIN; RETINOIC ACID RECEPTOR;

ACTION POTENTIAL; ARRHYTHMOGENESIS; ARTICLE; CARDIOTOXICITY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CELL DIFFERENTIATION; CELL SURVIVAL; CYTOTOXICITY; ELECTRIC ACTIVITY; ELECTRIC CONDUCTIVITY; EMBRYONIC STEM CELL; GAP JUNCTION; HEART ARRHYTHMIA; HEART CONDUCTION; HEART ELECTROPHYSIOLOGY; HEART MUSCLE CELL; HEART VENTRICLE FIBRILLATION; HUMAN; IN VITRO STUDY; ION CURRENT; LEOPARD SYNDROME; MUTAGENESIS; NONHUMAN; PHENOTYPE; PLURIPOTENT STEM CELL; PROTEIN LOCALIZATION; QT PROLONGATION; SHORT QT INTERVAL; SPECIES DIFFERENCE; STRESS STRAIN RELATIONSHIP; SUSPENSION CELL CULTURE; TISSUE ENGINEERING; TORSADE DES POINTES;

EID: 84876670794     PISSN: None     EISSN: 17406757     Source Type: Journal    
DOI: 10.1016/j.ddmod.2012.06.002     Document Type: Review

References (70)

1. J. Yu Induced pluripotent stem cell lines derived from human somatic cells Science 318 2007 1917 1920
2. K. Takahashi Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 2007 861 872
3. C. Mummery Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells Circulation 107 2003 2733 2740
4. B.S. Yoon Enhanced differentiation of human embryonic stem cells into cardiomyocytes by combining hanging drop culture and 5-azacytidine treatment Differentiation 74 2006 149 159
5. M. Fujiwara Induction and enhancement of cardiac cell differentiation from mouse and human induced pluripotent stem cells with cyclosporin-A PLoS One 6 2011 e16734
6. S. Takei Bone morphogenetic protein-4 promotes induction of cardiomyocytes from human embryonic stem cells in serum-based embryoid body development Am. J. Physiol. Heart Circ. Physiol. 296 2009 H1793 H1803
7. M.A. Laflamme Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts Nat. Biotechnol. 25 2007 1015 1024
8. L. Yang Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population Nature 453 2008 524 528
9. E. Willems Small-molecule inhibitors of the Wnt pathway potently promote cardiomyocytes from human embryonic stem cell-derived mesoderm Circ. Res. 109 2011 360 364
10. P.W. Burridge A universal system for highly efficient cardiac differentiation of human induced pluripotent stem cells that eliminates interline variability PLoS One 6 2011 e18293
11. C. Kim Non-cardiomyocytes influence the electrophysiological maturation of human embryonic stem cell-derived cardiomyocytes during differentiation Stem Cells Dev. 19 2010 783 795
12. W.Z. Zhu Neuregulin/ErbB signaling regulates cardiac subtype specification in differentiating human embryonic stem cells Circ. Res. 107 2010 776 786
13. Q. Zhang Direct differentiation of atrial and ventricular myocytes from human embryonic stem cells by alternating retinoid signals Cell Res. 21 2011 579 587
14. J.C. Mohr The microwell control of embryoid body size in order to regulate cardiac differentiation of human embryonic stem cells Biomaterials 31 2010 1885 1893
15. J. Zhang Functional cardiomyocytes derived from human induced pluripotent stem cells Circ. Res. 104 2009 e30 e41
16. A. Mehta Pharmacological response of human cardiomyocytes derived from virus-free induced pluripotent stem cells Cardiovasc. Res. 91 2011 577 586
17. J. Ma High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents Am. J. Physiol. Heart Circ. Physiol. 301 2011 H2006 H2017
18. L. Sartiani Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach Stem Cells 25 2007 1136 1144
19. T.G. Otsuji Progressive maturation in contracting cardiomyocytes derived from human embryonic stem cells: qualitative effects on electrophysiological responses to drugs Stem Cell Res. 4 2010 201 213
20. M. Pekkanen-Mattila Human embryonic stem cell-derived cardiomyocytes: demonstration of a portion of cardiac cells with fairly mature electrical phenotype Exp. Biol. Med. (Maywood) 235 2010 522 530
21. V. Di Felice HSP90 and eNOS partially co-localize and change cellular localization in relation to different ECM components in 2D and 3D cultures of adult rat cardiomyocytes Biol. Cell. 99 2007 689 699
22. N.L. Tulloch Growth of engineered human myocardium with mechanical loading and vascular coculture Circ. Res. 109 2011 47 59
23. N. Bursac Cardiac muscle tissue engineering: toward an in vitro model for electrophysiological studies Am. J. Physiol. 277 Pt 2 1999 H433 H444
24. M. Radisic Optical mapping of impulse propagation in engineered cardiac tissue Tissue Eng. Part A 15 2009 851 860
25. W.H. Zimmermann Tissue engineering of a differentiated cardiac muscle construct Circ. Res. 90 2002 223 230
26. Y.S. Zhao Construction of a unidirectionally beating 3-dimensional cardiac muscle construct J. Heart Lung Transplant. 24 2005 1091 1097
27. O. Caspi Tissue engineering of vascularized cardiac muscle from human embryonic stem cells Circ. Res. 100 2007 263 272
28. R.E. Akins Cardiac organogenesis in vitro: reestablishment of three-dimensional tissue architecture by dissociated neonatal rat ventricular cells Tissue Eng. 5 1999 103 118
29. D.D. Streeter Jr. Fiber orientation in the canine left ventricle during diastole and systole Circ. Res. 24 1969 339 347
30. I.J. LeGrice Laminar structure of the heart: ventricular myocyte arrangement and connective tissue architecture in the dog Am. J. Physiol. 269 Pt 2 1995 H571 H582
31. J.I. Luna Multi-scale biomimetic topography for the alignment of neonatal and embryonic stem cell-derived heart cells Tissue Eng. Part C Methods 17 2011 579 588
32. A. Chen Shrink-film configurable multiscale wrinkles for functional alignment of human embryonic stem cells and their cardiac derivatives Adv. Mater. 23 2011 5785 5791
33. S. Schaaf Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology PLoS One 6 2011 e26397
34. J. He Reduction in density of transverse tubules and L-type Ca(2+) channels in canine tachycardia-induced heart failure Cardiovasc. Res. 49 2001 298 307
35. S.K. Maier Distinct subcellular localization of different sodium channel alpha and beta subunits in single ventricular myocytes from mouse heart Circulation 109 2004 1421 1427
36. L.T. Izu Eavesdropping on the social lives of Ca(2+) sparks Biophys. J. 93 2007 3408 3420
37. M. Ibrahim Prolonged mechanical unloading affects cardiomyocyte excitation-contraction coupling, transverse-tubule structure, and the cell surface FASEB J. 24 2010 3321 3329
38. K.D. Costa Creating alignment and anisotropy in engineered heart tissue: role of boundary conditions in a model three-dimensional culture system Tissue Eng. 9 2003 567 577
39. E.J. Lee Engineered cardiac organoid chambers: toward a functional biological model ventricle Tissue Eng. Part A 14 2008 215 225
40. I. Kehat Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes J. Clin. Invest. 108 2001 407 414
41. T. Xue Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers Circulation 111 2005 11 20
42. 2+ wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes Stem Cells Dev. 18 2009 1493 1500
43. 2+ handling properties of human embryonic stem cell-derived cardiomyocytes by calsequestrin expression Am. J. Physiol. Cell Physiol. 297 2009 C152 C159
44. P. Schaffer Di-4-ANEPPS causes photodynamic damage to isolated cardiomyocytes Pflugers Arch. 426 1994 548 551
45. C.R. Bezzina Genetics of cardiomyopathy and channelopathy Heart Metab. 41 2008 5 10
46. R.P. Davis Pluripotent stem cell models of cardiac disease and their implication for drug discovery and development Trends Mol. Med. 17 2011 475 484
47. J.J. Unternaehrer, and G.Q. Daley Induced pluripotent stem cells for modelling human diseases Philos. Trans. R. Soc. Lond. B: Biol. Sci. 366 2011 2274 2285
48. X. Carvajal-Vergara Patient-specific induced pluripotent stem-cell-derived models of LEOPARD syndrome Nature 465 2010 808 812
49. J. Satin Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes J. Physiol. 559 Pt 2 2004 479 496
50. M. Nagashima Alternation of inwardly rectifying background K+ channel during development of rat fetal cardiomyocytes J. Mol. Cell. Cardiol. 33 2001 533 543
51. M. Tristani-Firouzi, and S.P. Etheridge Kir 2.1 channelopathies: the Andersen-Tawil syndrome Pflugers Arch. 460 2010 289 294
52. X. Su Microfluidic cell culture and its application in high-throughput drug screening: cardiotoxicity assay for hERG channels J. Biomol. Screen. 16 2011 101 111
53. I. Gussak Electrical Diseases of the Heart: Genetics, Mechanisms, Treatment, Prevention 2008 Springer
54. L. Virag The slow component of the delayed rectifier potassium current in undiseased human ventricular myocytes Cardiovasc. Res. 49 2001 790 797
55. A. Moretti Patient-specific induced pluripotent stem-cell models for long-QT syndrome N. Engl. J. Med. 363 2010 1397 1409
56. C. Patel, and C. Antzelevitch Pharmacological approach to the treatment of long and short QT syndromes Pharmacol. Ther. 118 2008 138 151
57. J.M. Polo Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells Nat. Biotechnol. 28 2010 848 855
58. K. Narsinh Derivation of human induced pluripotent stem cells for cardiovascular disease modeling Circ. Res. 108 2011 1146 1156
59. A.L. Lahti Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture Dis. Model. Mech. 5 2011 220 230
60. E. Matsa Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation Eur. Heart J. 32 2011 952 962
61. H. Kita-Matsuo Lentiviral vectors and protocols for creation of stable hESC lines for fluorescent tracking and drug resistance selection of cardiomyocytes PLoS One 4 2009 e5046
62. D.A. Elliott NKX2-5(eGFP/w) hESCs for isolation of human cardiac progenitors and cardiomyocytes Nat. Methods 8 2011 1037 1040
63. N.C. Dubois SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells Nat. Biotechnol. 29 2011 1011 1018
64. D. Van Hoof Identification of cell surface proteins for antibody-based selection of human embryonic stem cell-derived cardiomyocytes J. Proteome Res. 9 2010 1610 1618
65. H. Uosaki Efficient and scalable purification of cardiomyocytes from human embryonic and induced pluripotent stem cells by VCAM1 surface expression PLoS One 6 2011 e23657
66. F. Hattori Nongenetic method for purifying stem cell-derived cardiomyocytes Nat. Methods 7 2010 61 66
67. S. Awasthi Label-free identification and characterization of human pluripotent stem cell-derived cardiomyocytes using second harmonic generation (SHG) microscopy J. Biophotonics 5 2012 57 66
68. I. Itzhaki Modelling the long QT syndrome with induced pluripotent stem cells Nature 471 2011 225 229
69. 2+ exchanger is a determinant of excitation-contraction coupling in human embryonic stem cell-derived ventricular cardiomyocytes Stem Cells Dev. 19 2010 773 782
70. I. Huber Identification and selection of cardiomyocytes during human embryonic stem cell differentiation FASEB J. 21 2007 2551 2563